House Health Care - 2026-04-09 - 9:00AM
Discussion of S154, a proposed study of biomarker testing and its potential cost and defrayal implications; Deputy Commissioner Mary Block (DFR) urged the study be broadened and warned of potential state costs if CMS requires defrayal for mandates enacted since 2011.
AI-Generated Content
The text on this page is AI generated. Summaries, highlights, analysis, and video transcripts are all produced from the original source material.
AI can make mistakes, so if you spot one, and we will fix it for everyone.
Note: the source content is unaltered by us. Any content source we link to, be it a video, an audio recording, or a document, is presented exactly as its publisher released it. That publisher is usually a government body, sometimes an individual official or another organisation.
No transcript available.
